Roustem Nabioullin

Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies

Jayne M. Stommel, Alec C. Kimmelman, Haoqiang Ying et al. · Science · 2007 · 928 citations

Medicine, Cancer Biology, Oncology +17

Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer

Alec C. Kimmelman, Aram F. Hezel, Andrew J. Aguirre et al. · Proceedings of the National Academy of Sciences · 2008 · 159 citations · Full text

Medicine, Genetics, Oncology +16

Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages

Roustem Nabioullin, Saburo Sone, Kazuto Mizuno et al. · Journal of Leukocyte Biology · 1994 · 62 citations

Life Sciences, Immunology, Oncology +14

In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors

Y. John Zhang, Zhaolin Wang, Dennis Sprous et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Formation of Human IFN- <i>β</i> Complex with the Soluble Type I Interferon Receptor IFNAR-2 Leads to Enhanced IFN Stability, Pharmacokinetics, and Antitumor Activity in Xenografted SCID Mice

Sean D. McKenna, Kristin Vergilis, Antonio R. Arulanandam et al. · Journal of Interferon & Cytokine Research · 2004 · 34 citations

Life Sciences, Immunology, Pharmacokinetics +10